Search

everythinglearnresearchcommunity

for

Search:↓

AMH is a good marker for diagnosing PCOS, but global standards are needed.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

The combined therapy improved symptoms in PCOS patients.

Neurosteroids show promise for treating epilepsy and more research is needed.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

PCOS is managed with medication, lifestyle changes, and a healthy diet.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Women with PCOS have higher hair cortisol levels, which are linked to worse metabolic and inflammatory conditions.

High Lipid Accumulation Product levels are linked to more hirsutism in women with Polycystic Ovary Syndrome.

Free testosterone is the most common hormone marker in PCOS, and age affects DHEAS levels.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

PCOS may increase the risk of certain cancers.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

PCOS causes hormonal imbalances, irregular periods, and can lead to infertility, obesity, and mental health issues.

PCOS symptoms vary by age, affecting diagnosis and treatment.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.